搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Lysinibacillus sphaericus 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase (menD), partial CSB-YP539170LRV
CSB-EP539170LRV
CSB-BP539170LRV
CSB-MP539170LRV
CSB-EP539170LRV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lysinibacillus sphaericus Transcriptional regulator MntR (mntR) CSB-YP539171LRV
CSB-EP539171LRV
CSB-BP539171LRV
CSB-MP539171LRV
CSB-EP539171LRV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lysinibacillus sphaericus 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase (mtnX) CSB-YP539172LRV
CSB-EP539172LRV
CSB-BP539172LRV
CSB-MP539172LRV
CSB-EP539172LRV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lysinibacillus sphaericus Urease accessory protein UreG (ureG) CSB-YP539173LRV
CSB-EP539173LRV
CSB-BP539173LRV
CSB-MP539173LRV
CSB-EP539173LRV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator Bifunctional enzyme IspD/IspF (ispDF) CSB-YP539174DJM
CSB-EP539174DJM
CSB-BP539174DJM
CSB-MP539174DJM
CSB-EP539174DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator Phosphoglycerate kinase (pgk) CSB-YP539175DJM
CSB-EP539175DJM
CSB-BP539175DJM
CSB-MP539175DJM
CSB-EP539175DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator SsrA-binding protein (smpB) CSB-YP539176DJM
CSB-EP539176DJM
CSB-BP539176DJM
CSB-MP539176DJM
CSB-EP539176DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator 30S ribosomal protein S9 (rpsI) CSB-YP539177DJM
CSB-EP539177DJM
CSB-BP539177DJM
CSB-MP539177DJM
CSB-EP539177DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator 50S ribosomal protein L23 (rplW) CSB-YP539178DJM
CSB-EP539178DJM
CSB-BP539178DJM
CSB-MP539178DJM
CSB-EP539178DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator 50S ribosomal protein L16 (rplP) CSB-YP539179DJM
CSB-EP539179DJM
CSB-BP539179DJM
CSB-MP539179DJM
CSB-EP539179DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator 50S ribosomal protein L5 (rplE) CSB-YP539180DJM
CSB-EP539180DJM
CSB-BP539180DJM
CSB-MP539180DJM
CSB-EP539180DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator 50S ribosomal protein L11 (rplK) CSB-YP539181DJM
CSB-EP539181DJM
CSB-BP539181DJM
CSB-MP539181DJM
CSB-EP539181DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator 50S ribosomal protein L15 (rplO) CSB-YP539182DJM
CSB-EP539182DJM
CSB-BP539182DJM
CSB-MP539182DJM
CSB-EP539182DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator DNA repair protein recO (recO) CSB-YP539183DJM
CSB-EP539183DJM
CSB-BP539183DJM
CSB-MP539183DJM
CSB-EP539183DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator Phosphoglucosamine mutase (glmM) CSB-YP539184DJM
CSB-EP539184DJM
CSB-BP539184DJM
CSB-MP539184DJM
CSB-EP539184DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator 50S ribosomal protein L28 (rpmB) CSB-YP539185DJM
CSB-EP539185DJM
CSB-BP539185DJM
CSB-MP539185DJM
CSB-EP539185DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator tRNA (guanine-N (1)-)-methyltransferase CSB-YP539186DJM
CSB-EP539186DJM
CSB-BP539186DJM
CSB-MP539186DJM
CSB-EP539186DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator 5-methylthioadenosine/S-adenosylhomocysteine deaminase (mtaD) CSB-YP539187DJM
CSB-EP539187DJM
CSB-BP539187DJM
CSB-MP539187DJM
CSB-EP539187DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator Alanine--tRNA ligase (alaS), partial CSB-YP539188DJM
CSB-EP539188DJM
CSB-BP539188DJM
CSB-MP539188DJM
CSB-EP539188DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulforudis audaxviator Dihydrodipicolinate synthase (dapA) CSB-YP539189DJM
CSB-EP539189DJM
CSB-BP539189DJM
CSB-MP539189DJM
CSB-EP539189DJM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>